azacitidine

Phase II/III Trial Evaluates Azacitidine with Lenalidomide or Vorinostat in Myelodysplastic Syndromes

A randomized phase II/III trial is investigating the efficacy of azacitidine combined with lenalidomide or vorinostat in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.

Phase II Trial of Azacitidine and Gemtuzumab Ozogamicin in Older AML Patients

A phase II trial is investigating the combination of azacitidine and gemtuzumab ozogamicin for older patients with untreated acute myeloid leukemia.

Phase II Trial of Venetoclax and HMA in FLT3 Mutated AML Patients